General Information of the Compound
Compound ID |
CP0921562
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(S)-2-((S)-2-((S)-3-((S)-1-((S)-5-guanidino-2-((S)-5-guanidino-2-methylpentanamido)pentanoyl)pyrrolidine-2-carboxamido)-4-(naphthalen-1-yl)but-1-en-2-ylamino)-4,4-dimethylpentanamido)-4-methylpentanoic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C45H71N11O6
|
||||||||||||||||||
Molecular Weight |
862.134
|
||||||||||||||||||
Canonical SMILES |
C=C(N[C@@H](CC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](C)CCCNC(=N)N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C45H71N11O6/c1-27(2)24-35(42(61)62)55-39(58)36(26-45(5,6)7)52-29(4)34(25-31-17-10-16-30-15-8-9-18-32(30)31)54-40(59)37-20-13-23-56(37)41(60)33(19-12-22-51-44(48)49)53-38(57)28(3)14-11-21-50-43(46)47/h8-10,15-18,27-28,33-37,52H,4,11-14,19-26H2,1-3,5-7H3,(H,53,57)(H,54,59)(H,55,58)(H,61,62)(H4,46,47,50)(H4,48,49,51)/t28-,33-,34-,35-,36-,37-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
ZWPTXHCDOJTENR-GHJCEEMFSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02429, Neurotensin receptor type 1
Protein ID: PT02626, Neurotensin receptor type 2